marlanki schreef op 24 augustus 2018 12:57:
Dit is het laatstverschenen conceptrapport van ICER:
©Institute for Clinical and Economic Review, 2018
Draft Report – Lanadelumab and C1 Inhibitors for Long-Term Prophylaxis of HAE.
Hierna (wanneer??) volgt dus nog het definitieve rapport waarin alle nieuwe gegevens zijn verwerkt.
ICER blijft blijkbaar ook daarna de gegevens vergelijken t.b.v. CTAF = California Technology Assessment Forum.
"The findings contained within this report are current as of the date of publication. Readers should be aware that new evidence may emerge following the publication of this report that could potentially influence the results. ICER may revisit its analyses in a formal update to this report in the future."